Bilici, A. Et Al. 2019. Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY , vol.14, no.10 .

Bilici, A., Olmez, O. F., GÜRSOY, P., Cubukcu, E., Yildiz, O., Sakin, A., ... KORKMAZ, T.(2019). Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY , vol.14, no.10.

Bilici, A. Et Al. "Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer," JOURNAL OF THORACIC ONCOLOGY , vol.14, no.10, 2019

Bilici, A. Et Al. "Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer." JOURNAL OF THORACIC ONCOLOGY , vol.14, no.10, 2019

Bilici, A. Et Al. (2019) . "Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer." JOURNAL OF THORACIC ONCOLOGY , vol.14, no.10.

@article{article, author={A. Bilici Et Al. }, title={Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2019}